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Abstract
Background: Salmonella is a common intestinal pathogen that causes acute and chronic inflammatory response.
Probiotics reduce inflammatory cytokine production and serve as beneficial commensal microorganisms in the
human gastrointestinal tract. TGF-β (transforming growth factor β)/SMAD and NF-κB signaling play important roles
in inflammation in intestinal cells. However, the involvement of the signaling in regulating inflammation between
Salmonella and probiotics is not fully understood.
Methods: L. acidophilus and prebiotic inulin were used to treat human intestinal Caco-2 cells prior to infection with
Salmonella. The cells were harvested to examine the cytokines and MIR21 expression with immunoblotting and
real-time PCR. NF-κB and SMAD3/4 reporter vectors were transfected into cells to monitor inflammation and TGF-β1
signaling, respectively.
Results: In this study, we showed that the probiotic L. acidophilus decreased Salmonella-induced NF-κB activation
in human intestinal Caco-2 cells. Expression of the inflammatory cytokines, TNF-α and IL-8, in L. acidophilus-
pretreated cells was also significantly lower than that in cells infected with Salmonella alone. Moreover, TGF-β1 and
MIR21 expression was elevated in cells pretreated with L. acidophilus or synbiotic, a combination of inulin and L.
acidophilus, compared to that in untreated cells or cells infected with S. typhimurium alone. By contrast, expression
of SMAD7, a target of MIR21, was accordingly reduced in cells treated with L. acidophilus or synbiotics. Consistent
with TGF-β1/MIR21 and SMAD7 expression, SMAD3/4 transcriptional activity was significantly higher in the cells
treated with L. acidophilus or synbiotics. Furthermore, TGF-β1 antibody antagonized the SMAD3/4 and NF-κB
transcriptional activity modulated by L. acidophilus in intestinal cells.
Conclusion: Our results suggest that the TGF-β1/MIR21 signaling pathway may be involved in the suppressive
effects of L. acidophilus on inflammation caused by S. typhimurium in intestinal Caco-2 cells.
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Background
The human intestine houses a dense and diverse micro-
bial community, which is estimated to contain at least
500 different species of bacteria. These microbes, col-
lectively referred to as the commensal microbiota, play
important roles in human health, such as processing of
nutrients, regulation of fat storage [1, 2], and protection
against pathogens [3]. Salmonella typhimurium (S. typhi-
murium), an intestinal pathogenic bacterium, is one of
the most common non-typhoidal Salmonella (NTS),
which is the leading cause of acute food-borne disease
[4]. Salmonellosis results in diarrhea, vomiting, and fever
in the majority of people after infection. Approximately
400 persons die each year because of severe Salmonel-
losis, particular young children, the elderly, and the im-
munocompromised persons. S. typhimurium penetrates
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intestinal cells and macrophages to induce intestinal
inflammation using two type III secretion systems
(T3SSs) [5]. S. typhimurium induces NF-kB activation
and the secretion of pro-inflammatory cytokines, such as
interleuckin-8 (IL-8) [6] and tumor necrosis factor alpha
(TNF-α) [7]. The excessive inflammatory response may
help S. typhimurium eliminate other competitive micro-
biota in the host [8].
Probiotics attenuate NF-κB activation and inflammatory
cytokine production in intestinal epithelia cells [9, 10] and
in vivo [11–13]. These probiotics are considered beneficial
commensal microorganisms in human gastrointestinal
tract [14, 15]. TGF-β was identified as a negative regulator
of NF-κB activation in gut inflammation [16]. TGF-β acti-
vates SMAD2/3 and initiates SMAD4 dependent tran-
scription to induce IκBα, inhibitor of NF-κB, and
attenuate inflammatory responses [16], whereas SMAD7
physically inhibits the TGF-β receptor and induces the
pro-inflammatory pathways mediated by NF-κB [17]. Our
previous study showed that probiotics enhance enteric
protection against pathogens and reduce mucosal inflam-
mation by enhancing tumor growth factor beta (TGF-β)
signaling in vivo [18]. Recent reports also demonstrate
that TGF-β induces microRNA-21 (MIR21) expression,
which targets 3'-UTR of SMAD7 to attenuate its expres-
sion and enhances TGF-β signaling [19–21]. Furthermore,
probiotics decrease SMAD7 expression and elevate IκBα
expression to suppress pathogen-induced inflammation in
human gastric epithelia cells [9], suggesting that feed-back
control between TGF-β and SMAD7 may be crucial for
inflammation.
Although several studies demonstrated the suppres-
sion of inflammation using probiotics, the TGF-β-
mediated signaling caused by probiotics administra-
tion on S. typhimurium-induced inflammation in
human intestinal cells remains unclear. In this study,
we examined the role of TGF-β signaling molecules
in human intestinal Caco-2 cells infected with S.
typhimurium in the absence or presence of the pro-
biotic L. acidophilus alone or combination with the
prebiotic inulin, a non-digestible oligosaccharide that
enhances the growth of probiotics. We found that
TGF-β and MIR21 expression is induced, whereas
SMAD7 expression was decreased in human colorec-
tal Caco-2 cells pretreated with L. acidophilus com-
pared to cells infected with S. typhimurium alone.
SMAD3/4 transcriptional activity was further elevated
in L. acidophilus-treated cells, consistent with reduced
NF-kB transcriptional activity and inflammatory cyto-
kines induction, including IL-8 and TNF-α. Therefore,
our findings elucidate the effect of TGF-β signaling
on probiotics or synbiotics, which may identify a new
treatment strategy for inflammation caused by
Salmonella infection using probiotics.
Methods
Cell culture
The human colonic adenocarcinoma cell line (Caco-2,
BCRC 60182) was used in this study and cultured in
Dulbecco’s modified Eagle’s medium (DMEM) (Invitro-
gen, 12100–046) supplemented with 3.7 g/L NaHCO3
(Merck), 1.7 mM glutamine (Brunschwig Chemie BV),
100 U/ml penicillin, 100 μg/ml streptomycin, 0.25 μg/
ml amphotericin (Biological Industries), 0.01 mg/ml hu-
man transferrin (T-0665, Sigma-Aldrich), 1.0 mM so-
dium pyruvate, and 10 % (v/v) fetal bovine serum
(Biological Industries) at 37 °C in a humidified atmos-
phere of 5 % (v/v) CO2 in air. Cells were seeded in
75 cm2 tissue culture flasks (Corning Incorporated)
containing 8 ml DMEM medium. This study encom-
passed 10 cell passages of the cell line ranging from the
20th to the 29th passage.
S. typhimurium culture and infection
The enteric pathogen S. typhimurium (BCRC 10747) was
grown on a blood agar plate (BAP, trypticase soy agar with
5 % sheep blood) (CMP Ltd.) at 37 °C overnight. The bac-
terial colonies were collected with disposable L-shaped
cell spreaders in PBS (Biological Industries). The collected
bacteria were washed, centrifuged at 1,5000 × g for 15 min
at 4 °C and resuspended in PBS. The concentration of S.
typhimurium was measured using a spectrophotom-
eter as the optical density (OD) at 600 nm. For bacter-
ial infection, Caco-2 cells (1×106 cells/well) were
incubated with various concentrations S. typhimur-
ium, ranging from 1 × 104 CFU/ml to 1 × 1010 CFU/ml
in antibiotic-free DMEM for 1 h at 37 °C. The cells
were washed with PBS and recovered with DMEM media
containing gentamicin (50 μg/ml, Sigma-Aldrich) for the
following experiments.
Treatment of probiotic L. acidophilus
The probiotic L. acidophilus (BCRC 10695) was cultured
in DeMan, Rogosa, Sharpe (MRS) broth (CMP Ltd.) at
37 °C overnight. After centrifugation at 15000 × g for
15 min at 4 °C, the collected bacteria were washed once
with PBS (Biological Industries, 02-023-1) and subse-
quently resuspended with PBS for the treatment of
Caco-2 cells. Caco-2 cells (1×106 cells/well) were seeded
in a 6-well plate and treated with L. acidophilus (2 ×
107 CFU/ml/well, MOI = 20) in the presence or absence
of prebiotic (1 % inulin, Orafti ®GR) or probiotic in
antibiotic-free DMEM for 1 h. Subsequently, the Caco-2
cells were infected with S. typhimurium (1 × 107 CFU)
for 1 h and recovered with DMEM media containing
gentamicin (50 μg/ml, Sigma-Aldrich) for the following
experiments.
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Transfection and luciferase reporter assay
To test the SMAD and NF-κB transcriptional activity, the
Caco-2 cells in a 384-well plate were transfected with
50 ng of plasmid containing NF-κB-responsive reporter
vector pGL4.32 (Promega) or SMAD responsive reporter
vector pGL4.48 (Promega), which contains the NF-κB and
SMAD-binding sites, respectively. The pGL4.50 (Pro-
mega) constitutively expressing luciferase was used as a
normalization control. At 20 h post transfection, the cells
were infected with S. typhimurium in the absence of pres-
ence of probiotic or synbiotic for 1 h. The cells were
washed once with PBS and recovered with DMEM media
containing gentamicin (50 μg/ml, Sigma-Aldrich). The lu-
minescence of the luciferase-based reporter was measured
with DMEM medium containing 200 μM D-luciferin
(Promega). The results were read using a Fluoroskan
Ascent FL reader (Thermo Fisher Scientific).
Protein extraction and western blot
Human colorectal epithelia Caco-2 cells were briefly
rinsed in PBS (Biological Industries) and lysed with RIPA
buffer (1 % NP40 [MDBio, 101-9016-45-9], 50 mM Tris
HCl, pH 7.5, 150 mM NaCl, 0.25 % sodium deoxycholate
[Sigma-Aldrich, D6750], 0.1 % sodium dodecyl sulfate
[SDS; Calbiochem, 428015], and protease inhibitor cock-
tail [Roche, 11873580001]). The cell lysates were centri-
fuged at 13200 × g for 30 min and the supernatant was
collected to determine the protein concentration using
Bradford Reagent (Sigma-Aldrich). The cell lysates were
resolved by SDS-PAGE and transferred onto nitrocellu-
lose membranes using a wet electrophoretic transfer sys-
tem (Bio-Rad). The membrane was blocked with 5 %
skim milk and then incubated with primary antibodies
against SMAD7 (sc-11392) (Santa Cruz Biotech), TGF-β
(abcam) and actin (Sigma-Aldrich) to determine the pro-
tein expression using the ChemiDoc XRS Imaging System
(Bio-Rad) and analysis with Image Lab4.1 (Bio-Rad).
Real-Time PCR
The cells transfected with siRNA were used to extract the
total RNA with TRIzol Reagent (Invitrogen, 15596–018). A
total of 1 μg RNA was reverse-transcribed with SuperScript
II RNase H-Reverse Transcriptase (Invitrogen, 18064–014)
for cDNA synthesis. The amounts of IL-8, TNF-α and
MIR21 mRNA relative to S-26 were analyzed by real-time
PCR performed in a StepOnePlus™ system (Applied Bio-
systems) with the SYBR Green Master Mix (Applied Bio-
systems, 4385612). The primers for the genes are as
follows: IL-8 forward 5′- ACTGAGAGTGATTGAGAGT
GGAC-3′ and reverse 5′- AACCCTCTGCACCCAGTTT
TC −3′, TNF-α forward 5′- GAGGCCAAGCCCTGGG
ATG −3′ and reverse 5′- CGGGCCGATTGATCTCA
GC −3′, S-26 forward 5′- CCGTGCCTCCAAGATGA
CAAAG −3′ and reverse 5′- GTTCGGTCCTTGCG
GGCTTCAC −3′, and MIR21 reverse transcription
5′- CTCAACTGGTGTCGTGGAGTCGGCAATTCAG
TTGAGTCAACATC −3′ and gene specific forward
5′- CGGCGGTAGCTTATCAGACTGA −3′.
Data analysis
Data were statistically analyzed by Prism 5.0 (Graph-
Pad) using one-way ANOVA followed by Tukey’s mul-
tiple comparison test to compare the effects between
each group. All results are expressed as the mean ± SEM
from at least 3 individual experiments. The lev el of sig-
nificance was set at P < 0.05 (P-value ≦ 0.05 considered
significant (*), P-value ≦ 0.01 considered highly signifi-
cant (**), and P-value ≦ 0.001 considered extremely sig-
nificant (***)).
Results
L. acidophilus attenuates S. typhimurium-induced
inflammatory response in Caco-2 cells
NF-κB transcribes global genes involved in inflamma-
tion, such as TNF-α [22] and IL-8 [23]. To explore the
effect of probiotic on S. typhimurium-induced inflamma-
tion, an NF-κB responsive reporter assay was used to
optimize the infected concentration of S. typhimurium
for human intestinal cells. Human intestinal Caco-2 cells
were transfected with NF-κB responsive reporter vector
for 16 h and then incubated with S. typhimurium, ranging
from 1 × 106 ~ 1 × 1010 CFU/ml (MOI 1 to 10000), in
antibiotic-free media for 1 h (Fig. 1). The infected Caco-2
cells were recovered with media containing gentamicin to
monitor NF-κB transcriptional activity at 6 h or 24 h
post-infection. NF-κB transcriptional activity was sig-
nificantly increased 2.5- and 3-fold in Caco-2 cells
infected with S. typhimurium at 6 h post-infection in a
concentration of 1 × 106 CFU/ml (p≦ 0.05) and 1 ×
107 CFU/ml (p≦ 0.01), respectively (Fig. 1a). Therefore,
the optimal ratio for S. typhimurium to human colorec-
tal epithelia Caco-2 cells is an MOI 10 for this study.
Moreover, S. typhimurium entered host cells at 3 h
after infection (Additional file 1: Figure S1), suggesting
that S. typhimurium triggered inflammatory response
may be mainly resulted from extracellular stimuli,
most likely are the lipopolysaccharides of S. typhimur-
ium. Because L. acidophilus is one of the most com-
monly used probiotics in the food supply, we used L.
acidophilus as a probiotic for the following experi-
ments. Further, inulin is a well-known prebiotic that is
used to improve the growth and viability of probiotics
in fermented milk [24]. Therefore, we employed hu-
man intestinal Caco-2 cells harboring NF-κB respon-
sive reporter vector to infect with S. typhimurium
(MOI 10) without or with inulin or L. acidophilus
(MOI 20) or combination (synbiotic). Both L. acidoph-
ilus (MOI 20) and synbiotic significantly suppressed
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NF-κB transcriptional activity in cells infected with S.
typhimurium (p≦ 0.05) (Fig. 1b), whereas inulin alone
did not alter S. typhimurium-induced NF-κB transcrip-
tional activity. Furthermore, the mRNA level of IL-8 and
TNF-α, inflammatory cytokines and transcripts of NF-
κB, were significantly reduced in L. acidophilus and
synbiotic pretreated Caco-2 cells compared to the
cells infected with S. typhimurium alone (Fig. 2)
(p≦0.05), suggesting that the L. acidophilus and syn-
biotic decrease NF-kB activation, which in turn
inhibits inflammatory cytokine induction and reduces
the inflammation in human intestinal cells during S.
typhimurium infection.
L. acidophilus induces TGF-β and MIR21 expression
TGF-β, an important suppressor of inflammation, is in-
duced by L. acidophilus treatment in a mouse model
[18], whereas TGF-β expression did not change in hu-
man gastric epithelial cells [9]. The role of TGF-β in L.
acidophilus-treated human colorectal epithelia Caco-2
Fig. 1 Effects of L. acidophilus on S. typhimurium-induced NF-κB activation. a Human intestinal Caco-2 cells were transfected with a luciferase
reporter vector for NF-κB or CMV (normalization control) overnight and then infected with various concentrations of S. typhimurium as indicated,
ranging from 104 to 1010 CFU/ml in antibiotic-free DMEM for 1 h at 37 °C. The cells were recovered with DMEM media containing gentamicin
(50 μg/ml) and NF-κB transcriptional activity was measured at 6 or 24 h post-infection. b For treatment with L. acidophilus, transfected cells
were treated with 1 % inulin or L. acidophilus (L. acidophilus:S. typhimurium = 2:1) or synbiotics (L. acidophilus and 1 % inulin) 1 h prior to infection
of S. typhimurium as mentioned above. The cells were added with DMEM medium containing D-luciferin and antibiotic at 6 h post-infection
to measure NF-κB activity. The data were analyzed with Prism 5, and the results are shown as the means ± SEM from three independent experiments
Fig. 2 Effects of L. acidophilus and S. typhimurium on IL-8 and TNF-α mRNA expression. Human intestinal Caco-2 cells were treated with 1 % inulin
or L. acidophilus (L. acidophilus:S. typhimurium = 2:1) or synbiotics (L. acidophilus and 1 % inulin) 1 h prior to infection with S. typhimurium in DMEM
without antibiotic for 1 h. The cells were harvested at 6 h post-infection for mRNA isolation. The isolated mRNA was further used to
determine the expression of (a) IL-8 and (b) TNF-α by quantitative PCR (qPCR). The data are shown as the means ± SEM from three
independent experiments
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cells is not fully understood. To determine whether
TGF-β is involved in the anti-inflammation of L. acid-
ophilus in Caco-2 cells during S. typhimurium infection,
TGF-β expression in treated cells was assessed by im-
munoblotting (Fig. 3a). Both L. acidophilus and synbiotic
increased TGF-β expression in human intestinal Caco-2
cells during S. typhimurium infection. Moreover, TGF-β
enhances MIR21 maturation in primary cultured fibro-
blasts [19]; therefore, we further evaluated MIR21 expres-
sion in the treated Caco-2 cells (Fig. 3b). Consistently,
MIR21 expression was increased in cells with L. acidoph-
ilus or synbiotic, but not in the other treated cells, sug-
gesting that the TGF-β/MIR21 axis may be involved in the
anti-inflammatory effects of L. acidophilus in Caco-2 cells
post-infected with S. typhimurium.
L. acidophilus increases TGF-β/SMAD signaling in intes-
tinal cells
MIR21 targets 3'-UTR of SMAD7 and attenuates gene
expression [19], which may augment TGF-β signaling
for SMAD3/4 transcriptional activity, thereby playing an
important role in this positive feedback loop to suppress
inflammation. The protein expression of SMAD7 in S.
typhimurium infected cells with or without L. acidoph-
ilus was determined by immunoblotting (Fig. 4a). The
expression of SMAD7 was significantly increased in cells
infected with S. typhimurium compared to the uninfected
cells, whereas the cells pretreated with L. acidophilus
or synbiotic had a reduction in the increased expression
of SMAD7 (Fig. 4a). We further evaluated the SMAD3/
4 transcriptional activity with the cells harboring
SMAD3/4 responsive reporter vector. L. acidophilus in-
duced SMAD3/4 activity in intestinal cells with either
live or UV-inactivated S. typhimurium or LPS (Additional
file 2: Figure S2). Moreover, SMAD3/4 transcriptional ac-
tivity was increased 7-fold and 2.5-fold in cells adminis-
tered with L. acidophilus and synbiotics, respectively
(Fig. 4b). Pretreatment with synbiotics resulted in sig-
nificantly less activation of SMAD3/4 compared to the
cells treated with L. acidophilus alone, suggesting that
the combination of inulin and L. acidophilus has add-
itional effects on TGF-β/SMAD signaling. In addition,
the cells pretreated with TGF-β antibody modestly di-
minished the effects of L. acidophilus on SMAD3/4
and NF-κB transcriptional activity (Fig. 5), supporting
the hypothesis that L. acidophilus activates TGF-β sig-
naling to suppress inflammation caused by S. typhi-
murium in intestinal cells.
Discussion
Human immunity plays an important role in the develop-
ment of more serious clinical diseases after S. typhimur-
ium infection because of increased pro-inflammatory
cytokine expression in the intestine [25]. S. typhimurium
infection activates NF-κB in intestinal epithelium cells and
subsequently up-regulates gene transcription of pro-
inflammatory cytokines, such as IL-8 [26] and TNF-α
[22]. The present study demonstrates that S. typhimurium
Fig. 3 Effects of L. acidophilus and S. typhimurium on TGF-β and MIR21 expression. Human intestinal Caco-2 cells were treated with 1 % inulin or
L. acidophilus (L. acidophilus : S. typhimurium = 2:1) or synbiotics 1 h prior to infection with S. typhimurium in DMEM without antibiotic for 1 h. The cells
were harvested at 6 h post-infection for protein extraction. a The cells were lysed to extract the proteins and assess TGF-β expression by
immunoblotting. b The treated cells were harvested at 6 h post-infection for total RNA isolation. The isolated RNA was further used to determine the
expression of MIR21 by quantitative PCR (qPCR). The results are from three independent experiments, and the data are shown as the
means ± SEM. NS: not significant
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infection induces TNF-α and IL-8 pro-inflammatory
cytokine expression in human intestinal Caco-2 cells.
The previous study demonstrated that L. acidophilus
pretreatment decreases S. typhimurium induced in-
flammation [7]. The finding is consistent with the results
showing that anti-inflammatory effects are achieved by
probiotics in clinical setting [27]. In normal intestinal mu-
cosal cells, the TGF-β signal may negatively regulate NF-
κB activation by stimulating the negative regulator, IκBα
[16]. Silencing SMAD7 can restore TGFβ/SMAD3 signal-
ing and result in the suppression of inflammatory cytokine
production in patients with inflammatory bowel
Fig. 4 Effects of L. acidophilus and S. typhimurium on SMAD7 expression and SMAD3/4 transcriptional activity. a Human intestinal Caco-2 cells
were treated with 1 % inulin or L. acidophilus (L. acidophilus:S. typhimurium = 2:1) or synbiotics (L. acidophilus and 1 % inulin) 1 h prior to treatment
with S. typhimurium in DMEM without antibiotic for 1 h. The cells were harvested at 6 h post-infection for protein extraction. SMAD7 protein
expression was determined by immunoblotting. b Human intestinal Caco-2 cells were transfected with luciferase reporter plasmid for SMAD3/4 or CMV
(normalization control) overnight and then treated or infected as above. The cells were added DMEM medium containing D-luciferin at 6 h post-infection
to read the signal with a Luminometer. The quantitative results are shown as the means ± SEM from three independent experiments. NS: not significant
Fig. 5 Effects of TGF-β on L. acidophilus regulated SMAD3/4 and NF-κB transcriptional activity. Human intestinal Caco-2 cells were transfected with
luciferase reporter plasmid for a SMAD3/4 or b NF-κB overnight and then treated with L. acidophilus (L. acidophilus:S. typhimurium = 2:1) or
L. acidophilus mixed with anti-TGF-β antibody (1 μg/ml) 1 h prior to infection with S. typhimurium. The cells were recovered and added
DMEM medium containing D-luciferin at 6 h post-infection to read the signal with a Luminometer. The results are normalized with the
cells harboring luciferase constitutively expressed vector (CMV) and are shown as the means ± SEM from three independent experiments
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diseases [28]. Our results reveal that L. acidophilus in-
duces TGF-β/MIR21 expression and down-regulates
SMAD7 expression, which may decrease NF-κB-activated
inflammation caused by S. typhimurium in human intes-
tinal Caco-2 cells.
A prebiotic was first defined as a non-digestible food
ingredient that beneficially affects the host by selectively
stimulating the growth and/or activity of one or a lim-
ited number of bacteria in the colon and improving host
health [29]. Preliminary research on prebiotics demon-
strated potential effects on calcium and other mineral
absorption [30], immune system effectiveness [31],
bowel pH, reduction of colorectal cancer risk [32], and
inflammatory bowel disorders, such as Crohn's disease
and ulcerative colitis [33]. Additionally, Roberfroid
stated that only two particular prebiotics then fully meet
this definition, including trans-galactooligosaccharide
and inulin [29]. Inulin, a long-chain prebiotic, stimulates
the growth of probiotics [29]. Our results showed that
combination of probiotic and inulin as synbiotic had a
suppressive effect on the S. typhimurium-induced in-
flammatory cytokine production in human intestinal
Caco-2 cells, including IL-8 and TNF-α. However, syn-
biotics showed a smaller effect on TGF-β and MIR21 ex-
pression, and SMAD3/4 transcriptional activity compared
to the cells treated with L. acidophilus alone during infec-
tion with S. typhimurium. Previous report indicates that
prebiotic oligosaccharides reduce proinflammatory cyto-
kines in intestinal Caco-2 cells via activation of PPARγ
and peptidoglycan recognition protein 3 [34]. These re-
sults suggest that inulin may trigger additional signaling
events to prevent S. typhimurium-induced inflammation
in a TGF-β independent manner.
S. typhimurium is an intracellular bacterium that enters
cells after 2 h of infection. We infected Caco-2 cells with S.
typhimurium for only 1 h and recovered the cells with
media containing gentamicin. Therefore, the effects
on the NF-κB activation and inflammatory cytokines
induction might be resulted from lipopolysaccharides
of S. typhimurium. On the other hand, our current
study showed that L. acidophilus significantly induced
TGF-β/SMAD activity in intestinal cells. In addition
to TGF-β/MIR21 regulation on SMAD7 expression, L.
acidophilus inactivates Jak1/Stat1 signaling to decrease
SMAD7 expression, suggesting that Jak1/Stat1 may be
involved in the regulation of L. acidophilus on S.
typhimurium-induced SMAD7 expression [9]. It is ne-
cessary to further elucidate the detailed mechanisms
of TGF-β/SMAD regulation in human intestinal cells
treated with L. acidophilus.
Microbes play a pivotal role in intestinal homeosta-
sis, such as the uptake of nutrients and the generation
of essential elements. However, pathogen infection
may disrupt the homeostasis of intestinal microbes
and cause acute gastroenteritis or chronic inflamma-
tory diseases. Numerous clinical reports show that
probiotics play beneficial roles on reducing incidence
of gastrointestinal infectious diseases, including acute
diarrhea, necrotizing enterocolitis and death [35–37].
Our study showed that TGF-β1/MIR21 signaling path-
way may be involved in the suppressive effects of L.
acidophilus on inflammation in intestinal cells during
S. typhimurium infection. Previous reports also indi-
cate that prebiotics activate immune system in animals
during enteric pathogen infection [31]. However, our
current study show that prebiotic (inulin) has no effect
on diminishing inflammation in intestinal cells during
S. typhimurium infection, suggesting inulin may pref-
erentially modulate immune cells to reduce inflamma-
tion in vivo. Although the cell culture model may not
be able to precisely reflect actual infection due to
complicated nature of microbiota and host defense
system in vivo, our study provide a potential mechan-
ism of L. acidophilus on inflammation suppression in
intestinal cells during S. typhimurium infection.
Conclusion
Our current study indicates that L. acidophilus induces
TGF-β/MIR21 expression to reduce NF-κB-activated in-
flammation caused by S. typhimurium in human intes-
tinal Caco-2 cells. The TGF-β/MIR21 expression might
be used as a marker to evaluate anti-inflammatory ef-
fects of other strains of Lactobacillus, which requires
further study to determine the potential application.
Additional files
Additional file 1: Figure S1. Time required for S. typhimurium to enter
host cells. Human intestinal Caco-2 cells were incubated with S. typhimurium
(sal, 1×107 CFU per well) for 1, 2, or 3 h in a six-well plate. The cells were
subsequently washed with PBS, and the medium was replaced with
medium containing with antibiotics for 6 h. The cells were then lysed
with 1 % Triton X-100 (in PBS) to obtain the intracellular S. typhimurium.
Then, the lysates were incubated overnight on LB agar to determine the
time required for S. typhimurium to enter cells. (TIFF 234 kb)
Additional file 2: Figure S2. Effect of L. acidophilus on SMAD3/4
transcriptional activity with active or inactive S. typhimurium. Human
intestinal Caco-2 cells were transfected with luciferase reporter plasmid
containing the promoter of the SMAD-binding site or CMV promoter
overnight. The cells were then pretreated with L. acidophilus (MOI: 20)
1 h prior to infection with S. typhimurium (MOI: 10) or UV-inactivated S.
typhimurium (MOI: 10) in antibiotic-free DMEM for 1 h at 37 °C. Then, the
cells were washed twice with PBS and added to medium containing D-
luciferin to monitor SMAD activity. The cells were washed twice with PBS,
added to DMEM medium containing D-luciferin and antibiotics for
signal measurement with a Luminometer. Data were analyzed with
Prism 5, and the results are shown as the means ± SEM from three
independent experiments. (TIFF 100 kb)
Abbreviations
S. typhimurium: Salmonella typhimurium; L. acidophilus: Lactobacillus
acidophilus; TGF-β: Transforming growth factor beta; NF-κB: Nuclear
Factor-kappa B; CFU: Colony-forming unit; IL-8: Chemokine (C-X-C motif)
Huang et al. BMC Microbiology  (2015) 15:203 Page 7 of 9
ligand 8; TNF-α: Tumor necrosis factor alpha; SMAD7: SMAD family member 7;
MIR21: MicroRNA 21.
Competing interests
The authors declare that they have no competing interests
Authors’ contributions
Conceived and designed the experiments: CWS and HWC. Performed the
experiments: IFH, ICL, PFL, MFC and YCL. Analyzed the data: MFC, YDH and
JJC. Contributed reagents/materials/analysis tools: IFH, ICL, HWC. Wrote the
paper: CWS and IFH. All authors contributed to the final manuscript. All authors
read and approved the final manuscript.
Author details
IFH and MFC: Attending physician at Kaohsiung Veterans General Hospital,
Kaohsiung. YDH: assistant administrator at Kaohsiung Veterans General
Hospital, Pingtung. ICL: nutritionist at Zuoying Branch of Kaohsiung Armed
Forces General Hospital. YCL: research assistant at Kaohsiung Veterans
General Hospital, Kaohsiung. PFL: Post-doctor at Kaohsiung Veterans General
Hospital, Kaohsiung. JJC: professor at Tajen University. CLC: assistant professor
at National Sun Yat-sen University. HWC: professor at Kaohsiung Medical
University, Kaohsiung. CWS: associate research fellow at Kaohsiung Veterans
General Hospital, Kaohsiung.
Acknowledgments
This work was supported by Kaohsiung Veterans General Hospital
(VGHKS102-97 VGHNSU103-004 to I-Fei Huang, VGHKS100-125 to Chih-Wen
Shu), Zuoying Branch of Kaohsiung Armed Forces General Hospital (ZBH
104–26 to I-Chun Lin), and Kaohsiung Medical University “Aim for the Top
Universities Grant (KMU-TP103A33 to Hsueh-Wei Chang).
Author details
1Department of Pediatrics, Kaohsiung Veterans General Hospital, Kaohsiung,
Taiwan. 2Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan.
3Chung Hwa University of Medical Technology, Tainan, Taiwan. 4Diet and
Nutrition Section, Zuoying Branch of Kaohsiung Armed Forces General
Hospital, Kaohsiung, Taiwan. 5Department of Medical Education and
Research, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan.
6Department of Dentistry, Kaohsiung Veterans General Hospital, Pingtung,
Taiwan. 7Department of Pharmacy, Tajen University, Pingtung, Taiwan.
8Department of Biological Science, National Sun Yat-sen University,
Kaohsiung, Taiwan. 9Doctoral Degree Program in Marine Biotechnology,
National Sun Yat-sen University and Academia Sinica, Kaohsiung, Taiwan.
10Department of Biomedical Science and Environmental Biology, Kaohsiung
Medical University, Kaohsiung, Taiwan. 11Research Center of Environmental
Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
Received: 6 April 2015 Accepted: 2 October 2015
References
1. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut
microbiota as an environmental factor that regulates fat storage. Proc
Natl Acad Sci U S A. 2004;101(44):15718–23.
2. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI.
An obesity-associated gut microbiome with increased capacity for energy
harvest. Nature. 2006;444(7122):1027–31.
3. Mundy R, MacDonald TT, Dougan G, Frankel G, Wiles S. Citrobacter
rodentium of mice and man. Cell Microbiol. 2005;7(12):1697–706.
4. Schiller LR. Infectious disease: A germy world-food-borne infections in 2009.
Nat Rev Gastroenterol Hepatol. 2009;6(4):197–8.
5. Abrahams GL, Muller P, Hensel M. Functional dissection of SseF, a type III
effector protein involved in positioning the salmonella-containing vacuole.
Traffic. 2006;7(8):950–65.
6. Gewirtz AT, Rao AS, Simon Jr PO, Merlin D, Carnes D, Madara JL, et al.
Salmonella typhimurium induces epithelial IL-8 expression via Ca(2+)-mediated
activation of the NF-kappaB pathway. J Clin Invest. 2000;105(1):79–92.
7. Kim MS, Yoon YS, Seo JG, Lee HG, Chung MJ, Yum DY. A study on the
prevention of salmonella infection by using the aggregation characteristics
of lactic Acid bacteria. Toxicol Res. 2013;29(2):129–35.
8. Brown SP, Le Chat L, Taddei F. Evolution of virulence: triggering host
inflammation allows invading pathogens to exclude competitors. Ecol Lett.
2008;11(1):44–51.
9. Yang YJ, Chuang CC, Yang HB, Lu CC, Sheu BS. Lactobacillus acidophilus
ameliorates H. pylori-induced gastric inflammation by inactivating the
Smad7 and NFkappaB pathways. BMC Microbiol. 2012;12:38.
10. McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic use decreases intestinal
inflammation and increases bone density in healthy male but not female
mice. J Cell Physiol. 2013;228(8):1793–8.
11. Dimitrijevic R, Ivanovic N, Mathiesen G, Petrusic V, Zivkovic I, Djordjevic
B, et al. Effects of Lactobacillus rhamnosus LA68 on the immune
system of C57BL/6 mice upon oral administration. J Dairy Res.
2014;81(2):202–7.
12. Ivanovic N, Minic R, Dimitrijevic L, Radojevic Skodric S, Zivkovic I, Djordjevic
B. Lactobacillus rhamnosus LA68 and Lactobacillus plantarum WCFS1
differently influence metabolic and immunological parameters in high fat
diet-induced hypercholesterolemia and hepatic steatosis. Food Funct.
2015;6(2):558-65.
13. Li C, Nie SP, Zhu KX, Ding Q, Li C, Xiong T, et al. Lactobacillus plantarum
NCU116 improves liver function, oxidative stress and lipid metabolism in
rats with high fat diet induced non-alcoholic fatty liver disease. Food Funct.
2014;5(12):3216–23.
14. Chiu YH, Lu YC, Ou CC, Lin SL, Tsai CC, Huang CT, et al. Lactobacillus
plantarum MYL26 induces endotoxin tolerance phenotype in Caco-2 cells.
BMC Microbiol. 2013;13:190.
15. Chiu YH, Lin SL, Tsai JJ, Lin MY. Probiotic actions on diseases: implications
for therapeutic treatments. Food Funct. 2014;5(4):625–34.
16. Monteleone G, Pallone F, MacDonald TT. Smad7 in TGF-beta-mediated
negative regulation of gut inflammation. Trends Immunol. 2004;25(10):513–7.
17. Bitzer M, von Gersdorff G, Liang D, Dominguez-Rosales A, Beg AA, Rojkind M,
et al. A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa
B/RelA. Genes Dev. 2000;14(2):187–97.
18. Foye OT, Huang IF, Chiou CC, Walker WA, Shi HN. Early administration of
probiotic Lactobacillus acidophilus and/or prebiotic inulin attenuates
pathogen-mediated intestinal inflammation and Smad 7 cell signaling.
FEMS Immunol Med Microbiol. 2012;65(3):467–80.
19. Li Q, Zhang D, Wang Y, Sun P, Hou X, Larner J, et al. MiR-21/Smad 7 signaling
determines TGF-beta1-induced CAF formation. Sci Rep. 2013;3:2038.
20. Wang T, Zhang L, Shi C, Sun H, Wang J, Li R, et al. TGF-beta-induced miR-21
negatively regulates the antiproliferative activity but has no effect on EMT
of TGF-beta in HaCaT cells. Int J Biochem Cell Biol. 2012;44(2):366–76.
21. Kim YJ, Hwang SJ, Bae YC, Jung JS. MiR-21 regulates adipogenic differentiation
through the modulation of TGF-beta signaling in mesenchymal stem
cells derived from human adipose tissue. Stem cells (Dayton, Ohio).
2009;27(12):3093–102.
22. Dong J, Jimi E, Zeiss C, Hayden MS, Ghosh S. Constitutively active NF-kappaB
triggers systemic TNFalpha-dependent inflammation and localized TNFalpha-
independent inflammatory disease. Genes Dev. 2010;24(16):1709–17.
23. Hoffmann E, Dittrich-Breiholz O, Holtmann H, Kracht M. Multiple control of
interleukin-8 gene expression. J Leukoc Biol. 2002;72(5):847–55.
24. Karimi R, Azizi MH, Ghasemlou M, Vaziri M. Application of inulin in cheese
as prebiotic, fat replacer and texturizer: A review. Carbohydr Polym.
2015;119C:85–100.
25. Godinez I, Raffatellu M, Chu H, Paixao TA, Haneda T, Santos RL, et al.
Interleukin-23 orchestrates mucosal responses to Salmonella enterica
serotype Typhimurium in the intestine. Infect Immun. 2009;77(1):387–98.
26. Malago JJ, Nemeth E, Koninkx JF, Tooten PC, Fajdiga S, van Dijk JE.
Microbial products from probiotic bacteria inhibit Salmonella enteritidis
857-induced IL-8 synthesis in Caco-2 cells. Folia Microbiol (Praha).
2010;55(4):401–8.
27. Bested AC, Logan AC, Selhub EM. Intestinal microbiota, probiotics and mental
health: from Metchnikoff to modern advances: Part I - autointoxication
revisited. Gut Pathog. 2013;5(1):5.
28. Monteleone G, Fantini MC, Onali S, Zorzi F, Sancesario G, Bernardini S, et al.
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide
in patients with active Crohn's disease. Mol Ther. 2012;20(4):870–6.
29. Roberfroid M. Prebiotics: the concept revisited. J Nutr. 2007;137
(3 Suppl 2):830S–7S.
30. Scholz-Ahrens KE, Ade P, Marten B, Weber P, Timm W, Acil Y, et al. Prebiotics,
probiotics, and synbiotics affect mineral absorption, bone mineral content, and
bone structure. J Nutr. 2007;137(3 Suppl 2):838S–46S.
Huang et al. BMC Microbiology  (2015) 15:203 Page 8 of 9
31. Lomax AR, Calder PC. Prebiotics, immune function, infection and inflammation:
a review of the evidence. Br J Nutr. 2009;101(5):633–58.
32. Geier MS, Butler RN, Howarth GS. Inflammatory bowel disease: current
insights into pathogenesis and new therapeutic options; probiotics,
prebiotics and synbiotics. Int J Food Microbiol. 2007;115(1):1–11.
33. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and
prebiotics in inflammatory bowel disease: a review of clinical trials.
Proc Nutr Soc. 2007;66(3):307–15.
34. Zenhom M, Hyder A, de Vrese M, Heller KJ, Roeder T, Schrezenmeir J.
Prebiotic oligosaccharides reduce proinflammatory cytokines in intestinal
Caco-2 cells via activation of PPARgamma and peptidoglycan recognition
protein 3. J Nutr. 2011;141(5):971–7.
35. Sazawal S, Hiremath G, Dhingra U, Malik P, Deb S, Black RE. Efficacy of
probiotics in prevention of acute diarrhoea: a meta-analysis of masked,
randomised, placebo-controlled trials. Lancet Infect Dis. 2006;6(6):374–82.
36. Lin JS, Chiu YH, Lin NT, Chu CH, Huang KC, Liao KW, et al. Different effects
of probiotic species/strains on infections in preschool children: A double-
blind, randomized, controlled study. Vaccine. 2009;27(7):1073–9.
37. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, et al. Oral probiotics
prevent necrotizing enterocolitis in very low birth weight preterm infants:
a multicenter, randomized, controlled trial. Pediatrics. 2008;122(4):693–700.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Huang et al. BMC Microbiology  (2015) 15:203 Page 9 of 9
